Related Experiment Video
Updated: Aug 2, 2025
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.8K
SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
Xiaolei Sun1,2, Aixian Tian2, Peng Li3
1Tianjin Key Laboratory of Composite and Functional Materials, School of Materials Science and Engineering, Tianjin University, Tianjin, China.
Orthopaedic Surgery
|April 14, 2023
Summary
SCIMP gene is significantly decreased in postmenopausal osteoporosis (PMOP) patients and plays a critical role in bone metabolism by influencing osteoclast function via an Akt-dependent pathway, offering new therapeutic insights.
Area of Science:
- Molecular Biology
- Genetics
- Bone Biology
Background:
- Postmenopausal osteoporosis (PMOP) occurrence is linked to genetic susceptibility and cellular pathways.
- Not all postmenopausal women develop osteoporosis, suggesting specific genetic and cellular mechanisms are involved.
- Understanding the function of specific genes, like SCIMP, is crucial for elucidating PMOP pathogenesis.
Purpose of the Study:
- To investigate the role of the SCIMP gene in the pathogenesis of postmenopausal osteoporosis.
- To analyze the in vitro and in vivo functions of SCIMP in relation to bone metabolism.
- To explore the molecular pathways influenced by SCIMP in PMOP.
Main Methods:
- Differential gene expression analysis using GEO database and validation in clinical samples via ELISA.
- Bioinformatic analysis (GO and KEGG) to identify associated biological processes and signaling pathways.
- In vitro studies using MG-63 cells to assess SCIMP's effect on cell viability, proliferation, and apoptosis, and in vivo studies in rats.
Main Results:
- SCIMP was significantly down-regulated in PMOP patients compared to controls.
- SCIMP influences osteoclast differentiation and bone metabolism through the Akt signaling pathway.
- Upregulation of SCIMP enhanced bone structural parameters and osteogenic activity in vivo.
Conclusions:
- SCIMP is a critical factor in the pathogenesis of postmenopausal osteoporosis.
- SCIMP regulates osteoclast function and bone metabolism via an Akt-dependent pathway.
- Targeting SCIMP presents a potential new therapeutic strategy for osteoporosis.
